tetano
Editor, Senior Moderator
Arch Virol
. 2022 Feb 9.
doi: 10.1007/s00705-022-05368-z. Online ahead of print.
Investigational antiviral drugs for the treatment of COVID-19 patients
Samineh Beheshtirouy[SUP] 1 [/SUP], Elnaz Khani[SUP] 1 [/SUP], Sajad Khiali[SUP] 1 [/SUP], Taher Entezari-Maleki[SUP] 2 3 [/SUP]
Affiliations
Abstract
In the current pandemic of coronavirus disease 2019 (COVID-19), antiviral drugs are at the center of attention because of their critical role against severe acute respiratory disease syndrome coronavirus 2 (SARS-CoV-2). In addition to designing new antivirals against SARS-COV-2, a drug repurposing strategy is a practical approach for treating COVID-19. A brief insight about antivirals would help clinicians to choose the best medication for the treatment of COVID-19. In this review, we discuss both novel and repurposed investigational antivirals, focusing on in vitro, in vivo, and clinical trial studies.
. 2022 Feb 9.
doi: 10.1007/s00705-022-05368-z. Online ahead of print.
Investigational antiviral drugs for the treatment of COVID-19 patients
Samineh Beheshtirouy[SUP] 1 [/SUP], Elnaz Khani[SUP] 1 [/SUP], Sajad Khiali[SUP] 1 [/SUP], Taher Entezari-Maleki[SUP] 2 3 [/SUP]
Affiliations
- PMID: 35138438
- DOI: 10.1007/s00705-022-05368-z
Abstract
In the current pandemic of coronavirus disease 2019 (COVID-19), antiviral drugs are at the center of attention because of their critical role against severe acute respiratory disease syndrome coronavirus 2 (SARS-CoV-2). In addition to designing new antivirals against SARS-COV-2, a drug repurposing strategy is a practical approach for treating COVID-19. A brief insight about antivirals would help clinicians to choose the best medication for the treatment of COVID-19. In this review, we discuss both novel and repurposed investigational antivirals, focusing on in vitro, in vivo, and clinical trial studies.